Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Neuren Pharmaceuticals Limited has announced that Trevor Scott has stepped down from his director role as of June 30, 2024. He held a notable interest in the company, with 2,414,784 ordinary shares through Essex Castle Limited and Centralo Limited. This change in the company’s leadership could potentially impact investor outlook and stock performance.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
